LCB
"LCB" is a figurative mark owned by LigaChem Biosciences Inc., filed at the USPTO on December 24, 2024. It is registered and covers class 42 (Computer and Scientific Services).
- Status
- Registered
- Since January 6, 2026
- Filed
- December 24, 2024
- Registered
- January 6, 2026
- Expires
- Not recorded
- Application no.
- 98921341
- Registration no.
- 8091682
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 1 class
Who owns LCB
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
LigaChem Biosciences Inc.
Yuseong-gu, Daejeon, South Korea
Representative
Richard Y. Kim
Snell & Wilmer L.L.P.
What the mark covers
The products and services LCB is filed for, grouped by Nice class.
Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development, namely, pharmaceutical drug development services in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research, namely, medical research services relating to medicines in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticals, biotechnology and drugs; laboratory research services relating to pharmaceuticals; Technology research in the field of medical instruments; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical research and analysis
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- 1(b) basis deleted; proceed to registration
- Notice of allowance cancelled
- Noa e-mailed - sou required from applicant
- Post publication amendment - entered
- Assigned to petition staff
- Official gazette publication confirmation e-mailed
- Published for opposition
- Teas post publication amendment received
10 earlier steps on the official record.
About LCB
Who owns the trademark "LCB"?
The USPTO trademark "LCB" (application 98921341) is owned by LigaChem Biosciences Inc.
What is the status of "LCB"?
Its status at the USPTO is: registered.
When was "LCB" registered?
It was registered on January 6, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull LCB and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a3e-3b78-771f-b88a-8388ed32864c
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a3e-3b78-771f-b88a-8388ed32864c",
"object": "trademark",
"mark_text": "LCB",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98921341",
"filing_date": "2024-12-24",
"nice_classes": [
42
],
"owners": [
{
"name": "LigaChem Biosciences Inc.",
"entity_id": "ent_019ebab3-f279-71dd-b290-02506d26b60e"
}
]
}